New Amsterdam, LLC – Trademark Portfolio

Entity Type: 16

New Amsterdam, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HAMPTONS LEADERSHIP FORUM. The owner is based in East Hampton, NY.

18 Rivers Road

East Hampton, NY 11937

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

New Amsterdam, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does New Amsterdam, LLC have?

New Amsterdam, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.

What trademark classes does New Amsterdam, LLC file in?

New Amsterdam, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are New Amsterdam, LLC's most well-known trademarks?

New Amsterdam, LLC's registered trademark portfolio includes well-known marks such as HAMPTONS LEADERSHIP FORUM. These are among 1 currently registered trademark in the portfolio.

What is New Amsterdam, LLC's trademark registration success rate?

New Amsterdam, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.